Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levothyroxine sodium 100microgram tablets
0602010V0AABZBZ
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1,330,735 |
|
Alendronic acid 70mg tablets
0606020A0AAACAC
|
Alendronic acid | Alendronic acid | Endocrine System | 1,329,415 |
|
Metformin 500mg tablets
0601022B0AAABAB
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 1,221,487 |
|
Levothyroxine sodium 50microgram tablets
0602010V0AABXBX
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 1,199,790 |
|
Dapagliflozin 10mg tablets
0601023AGAAABAB
|
Dapagliflozin | Dapagliflozin | Endocrine System | 1,110,801 |
|
Levothyroxine sodium 25microgram tablets
0602010V0AABWBW
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 980,132 |
|
Finasteride 5mg tablets
0604020C0AAAAAA
|
Finasteride | Finasteride | Endocrine System | 851,334 |
|
Linagliptin 5mg tablets
0601023AEAAAAAA
|
Linagliptin | Linagliptin | Endocrine System | 567,205 |
|
Metformin 500mg modified-release tablets
0601022B0AAASAS
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 488,227 |
|
Sitagliptin 100mg tablets
0601023X0AAAAAA
|
Sitagliptin | Sitagliptin | Endocrine System | 430,598 |
|
Empagliflozin 10mg tablets
0601023ANAAAAAA
|
Empagliflozin | Empagliflozin | Endocrine System | 399,422 |
|
Metformin 1g modified-release tablets
0601022B0AAAVAV
|
Metformin hydrochloride | Metformin hydrochloride | Endocrine System | 396,970 |
|
Gliclazide 80mg tablets
0601021M0AAAAAA
|
Gliclazide | Gliclazide | Endocrine System | 389,504 |
|
Empagliflozin 25mg tablets
0601023ANAAABAB
|
Empagliflozin | Empagliflozin | Endocrine System | 373,128 |
|
Prednisolone 5mg tablets
0603020T0AAACAC
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | 307,571 |
|
Levothyroxine sodium 75microgram tablets
0602010V0AABYBY
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | 306,126 |
|
Alogliptin 25mg tablets
0601023AKAAACAC
|
Alogliptin | Alogliptin | Endocrine System | 296,337 |
|
Gliclazide 40mg tablets
0601021M0AAARAR
|
Gliclazide | Gliclazide | Endocrine System | 235,741 |
|
Risedronate sodium 35mg tablets
0606020R0AAADAD
|
Risedronate sodium | Risedronate sodium | Endocrine System | 199,949 |
|
NovoRapid FlexPen 100units/ml inj 3ml pre-filled pens
0601011A0BBADAC
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 197,489 |
|
Sukkarto SR 500mg tablets
0601022B0BMABAS
|
Sukkarto SR | Metformin hydrochloride | Endocrine System | 186,850 |
|
Sukkarto SR 1000mg tablets
0601022B0BMAAAV
|
Sukkarto SR | Metformin hydrochloride | Endocrine System | 185,394 |
|
Lantus 100units/ml inj 3ml pre-filled SoloStar pens
0601012V0BBAEAD
|
Insulin Lantus | Insulin glargine | Endocrine System | 183,126 |
|
Estradiol 0.06% gel (750microgram per actuation)
0604011G0AAAUAU
|
Estradiol (Systemic) | Estradiol | Endocrine System | 166,031 |
|
GlucoRx Nexus testing strips
0601060D0CUABA0
|
GlucoRx (Reagent) (Blood) | Glucose blood testing reagents | Endocrine System | 161,324 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.